Clinical Trial Update: Study of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating atezolizumab with split-dose gemcitabine plus cisplatin for locally advanced or metastatic urothelial carcinoma has completed, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Spanish Oncology Genito-Urinary Group | Conditions: Locally Advanced or Metastatic Urothelial Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2025-04-24